Literature DB >> 6667

Factors affecting the binding of tricyclic tranquillizers and antidepressants to human serum albumin.

D Sharples.   

Abstract

The linear free energy-related model for structure activity relations developed by Hansch & Fujita (1964) has been used to correlate the binding of tricylic tranquillizers and antidepressants to human serum albumin (HSA) with hydrophobic and electronic parameters. The parameters chosen being the chromatographic parameter (Rm) and the affinity of charge transfer complex formation (kc). The relative importance of these factors has been assessed by linear and multiple linear regression analysis. Results show that the major factor in binding is electronic with only a minor contribution from the hydrophobic parameter.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6667     DOI: 10.1111/j.2042-7158.1976.tb04106.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.

Authors:  E Pike; P Kierulf; B Skuterud; J E Bredesen; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

3.  The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

4.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications.

Authors:  Mingzhu Zhao; Dongqing Wei
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

Review 6.  Combination therapeutics in complex diseases.

Authors:  Bing He; Cheng Lu; Guang Zheng; Xiaojuan He; Maolin Wang; Gao Chen; Ge Zhang; Aiping Lu
Journal:  J Cell Mol Med       Date:  2016-09-07       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.